• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911412350
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Chest Pain (1776); Dyspnea (1816); Fatigue (1849)
Event Date 05/22/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) study.It was reported that the patient experienced dyspnea and atrial fibrillation.In (b)(6) 2013, clinical status assessment indicated that the patient's qualifying condition was myocardial infarction (mi) and stable angina.Elevated biomarkers indicated ischemia prior to procedure.Subsequently, index procedure was performed.The target lesion #1 was located in the 1st obtuse marginal (om) with 80% stenosis and was 9mm long with a reference vessel diameter of 3.7mm.The lesion #1 was treated with pre-dilatation and placement of a 3.50x12mm study stent with 0% residual stenosis.The target lesion #2 was located in the distal right coronary artery (rca) with 99% stenosis and was 7mm long with a reference vessel diameter of 3.1mm.The lesion #2 was treated with pre-dilatation and placement of a 3.00x12mm study stent with 0% residual stenosis.On the following day, the patient was discharged on dual antiplatelet therapy.In (b)(6) 2017, the patient presented to the hospital due to shortness of breath, worsening dyspnea on exertion, fatigue and chest pain.The patient had an exercise echocardiogram (stress test) which was negative for ischemia with no wall motion abnormalities.Since the patient's symptoms were concerning, the patient was referred for cardiac catheterization.Thirteen days later, the patient was presented to the hospital for an elective coronary artery bypass graft (cabg) and a left atrial appendage ligation.On the same day, the patient underwent coronary artery bypass graft (cabg) procedure from saphenous vein graft (svg) to right posterolateral artery (rpla) and svg to om.Additionally the patient also underwent cabg procedure from left internal mammary artery (lima) to left anterior descending artery (lad), and svg to diagonal.The patient was transferred to the cardiovascular intensive care unit (cvicu) post operation for recovery, acute intensive care unit (icu) and ventilator management.During the course of hospitalization, the patient developed atrial fibrillation with rapid ventricular rate (rvr) and was transferred back to the icu for possible cardioversion.Cardiac electrophysiology was consulted and since the patient was asymptomatic atrial fibrillation was treated medically.The patient was started on amiodarone and lopressor and atrial fibrillation was controlled.Eight days post-procedure, the patient was transferred back to the geriatric psychiatric unit (gpu) in stable condition.The following day the patient underwent successful direct current cardioversion (dccv) x 1 to sinus rhythm (sr) with electrophysiology (ep).Av wires were removed after 24 hours without complications.In (b)(6) 2017, the patient was discharged in stable condition on aspirin, lopressor and statin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6649234
MDR Text Key77821994
Report Number2134265-2017-06250
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 06/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/17/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/08/2013
Device Model NumberH7493911412350
Device Catalogue Number39114-1235
Device Lot Number15601126
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/02/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/22/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
-
-